CD8A and uremia: In line with our findings, Crèpin and colleagues described a decrease in naïve CD4+ and CD8+ T cells and an increase in CD28−CD57− terminally differentiated CD4+ and CD8+ T cells when comparing patients with chronic kidney disease (stage IV and dialyzed) and patients without uremia (Crépin et al., 2020).